Peptide Liquid Sprays
BPC-157 + TB-500 Blend Spray
BPC-157 + TB-500 liquid spray, clearly measured. 30 mg of each peptide in a 30 mL metered spray bottle, 1 mg per mL of each, ready to use.
✓ In stock and ready to ship
Certificate of analysis View available reports and lot details
Product identification & intended use
SKU: SC-SPRY-BPC/TB-60MG
For laboratory research use only. Not for human or veterinary use.
Description
This is the equal-ratio BPC-157 + TB-500 blend as a ready-to-use liquid: 30 mg of each peptide in a 30 mL bottle with a metered spray top, or 1 mg per mL of each. Available analytical documentation is listed in the COA library.
Chemical identity & storage
| Compound / component | CAS number | Molecular weight | Specification status |
|---|---|---|---|
| BPC-157 | 137525-51-0 | 1419.5 g/mol Formula: C62H98N16O22 |
Catalog reference specification |
| TB-4 fragment (Ac-LKKTETQ) | 885340-08-9 | 889.02 g/mol Formula: C38H68N10O14 |
Formulation-specific label specification for capsules, sprays, GLOW and KLOW. |
This spray/capsule formulation uses the acetylated TB-4 fragment. No single mixture CAS number or molecular weight is assigned.
Storage: Keep refrigerated at 2–8°C, protected from light. Keep the container closed and do not freeze unless the supplied label or lot documentation specifically directs otherwise.
What the spray is.
It combines BPC-157, a 15-residue piece of a stomach protein, with TB-500, which is modelled on thymosin beta-4, a protein that binds actin. They are often studied together because they appear to act in different ways.
There is nothing to reconstitute, which suits designs that call for a solution ready to use. The labeled amounts are totals for the full bottle, so each concentration is that amount divided by 30 mL.
At a glance.
| BPC-157 | 30 mg per bottle (1 mg/mL) |
|---|---|
| TB-500 | 30 mg per bottle (1 mg/mL) |
| Ratio | 1 : 1 |
| Volume | 30 mL |
| Format | Liquid, metered spray top |
| Catalog reference | SBL-8538 |
What the research looks at.
Studies on both peptides reach into soft tissue, wounds and the nervous system. In rodents, thymosin beta-4 has been examined after brain injury and stroke for its effect on new neurons and oligodendrocytes, and BPC-157 after spinal-cord and brain injury. Nobody has studied the combined spray in people.
Other formats.
The same blend comes as a lyophilized vial or capsules. For BPC-157 alone in liquid form, see the BPC-157 liquid spray.
Documentation.
Available analytical documentation is organized by compound, strength and format in the COA library. Do not treat a report as lot-specific unless a documented lot match is shown.
Handling.
There is nothing to mix: the liquid arrives ready, in a 30 mL bottle with a metered pump. Store it closed and standing up, out of heat and sunlight, as its label directs.
Questions.
How much of each peptide is in the bottle?
30 mg of BPC-157 and 30 mg of TB-500, in 30 mL.
Does it need reconstituting?
No. It comes as a finished liquid.
Is this for human use?
No. It is sold for laboratory research only.
Further reading.
BPC-157 formats compared: vials, capsules and spray
For laboratory research use only. Not for human or veterinary use.
